Currently, Cg Oncology Inc [CGON] is trading at $40.71, up 7.13%. An important factor to consider is whether the stock is rising or falling in short-term value. The CGON shares have gain 3.17% over the last week, with a monthly amount glided 21.63%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cg Oncology Inc [NASDAQ: CGON] stock has seen the most recent analyst activity on October 08, 2025, when Guggenheim initiated its Buy rating and assigned the stock a price target of $90. Previously, Piper Sandler started tracking the stock with Overweight rating on August 19, 2025, and set its price target to $55. JP Morgan started tracking the stock assigning a Overweight rating and suggested a price target of $41 on May 02, 2025. Scotiabank initiated its recommendation with a Sector Perform and recommended $23 as its price target on April 16, 2025. In a note dated October 24, 2024, UBS initiated an Buy rating and provided a target price of $60 on this stock.
This stock has fluctuated between a low of $14.80 and a high of $40.65 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $74.67 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $40.71 at the most recent close of the market. An investor can expect a potential return of 83.42% based on the average CGON price forecast.
Analyzing the CGON fundamentals
Trailing Twelve Months sales for Cg Oncology Inc [NASDAQ:CGON] were 0.55M which represents -100.00% decline. Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at -285.46%, Pretax Profit Margin comes in at -232.45%, and Net Profit Margin reading is -157.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.13 and Total Capital is -0.23. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 38.72 points at the first support level, and at 36.72 for the second support level. However, for the 1st resistance point, the stock is sitting at 42.49, and for the 2nd resistance point, it is at 44.26.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cg Oncology Inc [NASDAQ:CGON] is 22.15. On the other hand, the Quick Ratio is 22.15, and the Cash Ratio is 0.48. Considering the valuation of this stock, the price to sales ratio is 5643.71, the price to book ratio is 4.63.
Transactions by insiders
Recent insider trading involved POST LEONARD E, Director, that happened on Sep 30 ’25 when 5000.0 shares were sold. Director, Mulay James completed a deal on Sep 29 ’25 to sell 12755.0 shares. Meanwhile, Director LEONARD E POST bought 5000.0 shares on Sep 30 ’25.
